Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check14 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has removed the detailed options for downloading data in various formats, including CSV, JSON, and RIS, along with the associated data fields and selection options.SummaryDifference14%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.SummaryDifference16%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.7%
Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.